Recombinant CEACAM5 & CD3E (Cibisatamab Biosimilar) 抗体
This Human 单克隆 antibody specifically detects CEACAM5 & CD3E (Cibisatamab Biosimilar) in ELISA 和 WB. It exhibits reactivity toward 人.
产品编号 ABIN7538087
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CEACAM5 & CD3E (Cibisatamab Biosimilar) 抗体 (ABIN7538087)
抗原
CEACAM5 & CD3E (Cibisatamab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Cibisatamab Biosimilar – Anti-CEACAM5 & CD3E mAb - Research Grade
-
产品特性
- Antibody Type: Bispecific mAb with Domain Crossover
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
亚型
- IgG1 kappa, IgG1 lambda
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CEACAM5 & CD3E (Cibisatamab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research.
-
CAS-编号
- 1855925-27-7
抗原
-
You are here:
